Trial Profile

A Randomized Study to Analysis the Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 21 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Estradiol (Primary) ; Choriogonadotropin alfa; Follitropin beta; Ganirelix
Indications Infertility
Focus Therapeutic Use

Most Recent Events

21 Jul 2022 New trial record
30 Jun 2022 Primary endpoint (The number of oocytes retrieved by the IVG 36 hours after hCG administration) has not been met as per results published in the Human Reproduction
30 Jun 2022 Results published in the Human Reproduction

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com